sábado, 21 de junio de 2025

GLP-1 reduced migraine frequency by nearly half, in a pilot study Results of the small study were presented at a meeting of the European Academy of NeurologyGLP-1 reduced migraine frequency by nearly half, in a pilot study Results of the small study were presented at a meeting of the European Academy of Neurology

https://www.statnews.com/2025/06/20/glp-1-drugs-cut-migraine-frequency-in-half-pilot-study-called-hugely-interesting/

No hay comentarios: